Trupanion

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Trupanion reports robust 2022 growth, eyes international expansion opportunities

Trupanion delivered strong financial performance in 2022, with significant revenue and income growth driven by pet acquisitions and retention strategies.
The company's focus on efficient capital deployment, expansion into new channels, and cash reserve position it well for future growth and profitability.
While facing challenges from pricing dynamics and international expansion, Trupanion's strategic initiatives present opportunities for sustained growth and market expansion.
With a positive outlook for 2023 and a solid foundation of customer data, Trupanion is poised to leverage its strengths and navigate challenges for continued success.

Trupanion reports robust Q1 earnings, eyes global expansion opportunities

Trupanion's Q1 2023 earnings call showcased strong financial performance, strategic focus on managing challenges related to inflation, and opportunities for global expansion and market growth. The company's effective pricing strategies and emphasis on long-term vision position it well for revenue growth and margin expansion in 2023.

Trupanion reports robust Q2 performance, eyes growth opportunities ahead

Trupanion's Q2 2023 performance reflects strong revenue growth, margin stabilization, and strategic cost management.
The company aims for disciplined growth, margin expansion, and sustained ARPU amidst challenges in revenue diversification and cost optimization.
Opportunities lie in continued rate increases, marketing efficiency improvements, and enhanced reporting for customer engagement and financial performance.

Trupanion reports robust Q3 earnings, eyes disciplined growth strategies

Trupanion's Q3 performance reflects strong revenue growth, margin expansion, and improved cash flow, underpinned by pricing power and customer loyalty.
While facing challenges in diversifying revenue streams and entering new markets, the company is well-positioned to leverage growth opportunities and maintain financial stability.
With a focus on disciplined growth, operational efficiency, and strategic investments, Trupanion aims to sustain positive momentum and capitalize on the growing pet insurance market.

Trupanion reports robust Q4 growth, focuses on margin expansion

Trupanion's Q4 performance reflects resilience amid industry challenges, with a strong focus on sustainable growth and financial discipline. The company's strategic initiatives to enhance member experience, prioritize margin expansion, and optimize capital deployment position it well for future opportunities.

Trupanion reports robust Q1 performance amidst market challenges and opportunities

Trupanion's Q1 2024 performance reflects strong revenue growth, margin expansion, and operational improvements driven by customer-centric strategies and efficient capital deployment.
While facing challenges such as inflation impacts and remediation efforts, the company's focus on margin expansion, market opportunities, and strategic initiatives positions it for future growth.
Investors can be optimistic about Trupanion's ability to navigate challenges, capitalize on growth opportunities, and drive profitability through effective pricing and operational efficiency.

Trupanion reports robust Q3 performance, eyes growth opportunities in Europe

Trupanion's Q3 performance reflects strong growth in subscription income and strategic initiatives to drive profitability and market expansion.
While challenges persist with inflation and cost management, the company's focus on efficiency and growth presents opportunities for sustained success.
Investors should note the positive operational improvements, the strategic market expansion into Europe, and the commitment to achieving sustainable margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Chewy

Freshpet

Even shibas can appreciate what these companies are doing for them.

Forget Dogecoin: These 3 Pet-Friendly Stocks Are Better Investments

SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that members of Trupanion's management team will participate in the following upcoming investor conferences:

Trupanion Announces June Investor Conference Participation

Webinar includes top experts in both pet and human health including Trupanion's Chief Veterinary Officer Dr. Steve Weinrauch, Dr. Carrie Jurney, Dr. Valli Parthasarathy, and Dr. Sally Broder. Webinar includes top experts in both pet and human health including Trupanion's Chief Veterinary Officer Dr. Steve Weinrauch, Dr. Carrie Jurney, Dr. Valli Parthasarathy, and Dr. Sally Broder.

“Pets, Kids and The New Normal”: Trupanion Hosts a NEW Webinar to Ease High Anxiety For Pet Owners Returning to Work, and Their Pets Left at Home

Is this a great business that's temporarily out of favor, or will it have problems turning revenue growth into profit?

Trupanion's Stock Is Down More Than 30% This Year; Should You Buy the Dip?

Pet insurance may seem like a boutique business, but it is a wildly rewarding one.

Is Trupanion a Buy?

Etsy

Shopify

Block

Analysts believe these high-growth stocks could deliver significant gains to investors over the next year.

4 Unstoppable Stocks With 34% to 51% Upside, According to Wall Street

Boqii Holding

PetIQ

PetMed Express

Petco Health and Wellness

Zoetis

While the market has taken a beating over recent days, pullbacks are the mother's milk of effective investment strategies, and shrewd market participants will already have a growing shopping list on hand. With that in mind, one area that may deserve special attention and offer outsized potential ahead is the pet care space.

Growth Stock Spotlight: Acquisition Pits CSOC as Fresh Option in Booming Petcare Market

Trupanion (TRUP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

Moving Average Crossover Alert: Trupanion (TRUP)

Investors want to know if the beaten-down pet insurance stock can turn itself around.

Should You Buy Trupanion in May?

Trupanion, Inc. (TRUP) CEO Darryl Rawlings on Q1 2021 Results - Earnings Call Transcript

SEATTLE, April 29, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, will host its Annual Meeting of Stockholders on Wednesday, June 16, 2021. We will first conduct the formal shareholder meeting, to be followed by the extended informational session that has become our signature annual event for shareholders to engage with management.

Trupanion to Host 2021 Annual Meeting of Stockholders on June 16

SEATTLE, April 29, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2021.

Trupanion Reports First Quarter 2021 Results

SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has published its 2020 annual shareholder letter from CEO and Founder, Darryl Rawlings. The annual shareholder letter is now available on Trupanion's Investor Relations website here.

Trupanion Publishes Annual Shareholder Letter

Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Trupanion (TRUP) Expected to Beat Earnings Estimates: Should You Buy?

Fastly

Vertex Pharmaceuticals

Bargains abound if you're shopping for high-quality growth stocks.

The Growth Stock Sale of 2021 Has Arrived: 3 Stocks to Buy Now

SEATTLE, April 15, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2021 first quarter after the market closes on Thursday, April 29, 2021. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.

Trupanion, Inc. Announces First Quarter 2021 Earnings Release and Conference Call

Elanco Animal Health Inc

Northern Star Acquisition Corp

Not all pet companies are created equal. These pet stocks are positioned for upside as the industry witnesses steady growth.

7 Pet Stocks That Make Good Long-Term Holdings

Pinterest

Redfin

Teladoc

These innovative companies could help you run circles around the broader market by 2030.

5 Unstoppable Stocks That Can Return 500% This Decade

Nano-X Imaging

Novavax

Analysts' enthusiasm for these stocks appears to be justified.

3 Stocks to Buy That Wall Street Thinks Will Soar 50% or More

This insurer is an emerging leader in a largely untapped market.

1 Insurance Stock That Could Be a Huge Winner

Webinar includes global experts in pet health including Dr. Colin Basler, deputy director of the CDC's One Health Office, Dr. Steve Weinrauch, Dr. Carrie Jurney, Dr. Scott Weese, and Dr. Michael Lappin Webinar includes global experts in pet health including Dr. Colin Basler, deputy director of the CDC's One Health Office, Dr. Steve Weinrauch, Dr. Carrie Jurney, Dr. Scott Weese, and Dr. Michael Lappin

COVID-19 and Pets: An update From Trupanion and the COVID Council

Digital Turbine

Lovesac Company

Okta

Repligen

These names are major disruptors in their respective industries. Could one of them be the next Tesla?

7 Big Names That Could Be the Next Tesla

IDEXX Laboratories

Here's how you can profit off the booming $54 billion veterinary care industry.

3 Top Pet Healthcare Stocks to Buy Now

Intuitive Surgical

Visa

These great companies are your ticket to financial independence.

5 Surefire Stocks That Can Give You Financial Freedom

Brookfield Renewable Partners

Editas Medicine

All three of these stocks appear to be great comeback candidates.

News for Trupanion Stock (TRUP)